Skip to main content

Table 1 An overview of clinical data in inpatients with pneumonia (n = 38,870)

From: Hospitalization, case fatality, comorbidities, and isolated pathogens of adult inpatients with pneumonia from 2013 to 2022: a real-world study in Guangzhou, China

Variable

Value, n (%) or median (Q25, Q75)

Department

 

 Respiratory medicine

31,219 (80)

 Other internal medicine

5731 (15)

 Surgery

1920 (5)

Sex

 

 Female

11,846 (30)

 Male

27,024 (70)

Age (year)

64 (53, 73)

BMI (kg/m2)

21.6 (19.0, 24.2)

Smoking history

 

 Never smoker

25,254 (65)

 Ever smoker

6797 (17)

 Current smoker

6819 (18)

Glucocorticoid use during hospitalization

 

 No

22,442 (58)

 Yes

16,428 (42)

Immunosuppressant use during hospitalization

 

 No

19,799 (51)

 Yes

19,071 (49)

Cost (yuan)

19,107.2 (12,127.0, 34,275.0)

Length of stay (day)

7.9 (5.1, 12.8)

ICU admission

 

 No

36,511 (94)

 Yes

2359 (6)

Receiving mechanical ventilation during hospital

 

 No

25,267 (65)

 Yes

13,603 (35)

Discharge outcome

 

 Unknown

4786 (12)

 Improved

31,833 (82)

 Worsen

950 (2)

 Dead

1301 (3)

Pulmonary fungal infection

 

 No

33,526 (86)

 Yes

5344 (14)

Viral pneumonia

 

 No

38,412 (99)

 Yes

458 (1)

Albumin (g/L)

35.0 (31.3, 38.2)

White blood cell (*109/L)

8.1 (6.1, 11.0)

Erythrocyte sedimentation rate (mm/h)

46 (20, 85)

Hypersensitive C-reactive protein (mg/L)

20.5 (3.32, 71.2)

Procalcitonin

 

 Normal

10,828 (48)

 Elevated

11,758 (52)

 Missing

16,284